Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been fully informed about the study, its goals, what it involves, and their rights as a participant, and who have freely agreed to take part by signing a consent form
- People who are covered by a health insurance plan
- People who are able to attend follow-up appointments over a period of 36 months
- People who have had a stroke in the past 10 days (confirmed by a specific type of brain scan called an MRI) without any bleeding in the brain, OR people who have had a mini-stroke (also called a TIA) in the past 10 days with a risk score above 3 on a standard medical scale (called the ABCD2 score), again without bleeding in the brain
Who may not be able to join:
- People who are currently taking part in another medical research study, have done so in the past three months, or are still within a waiting period set by a previous study
- People who are under legal guardianship or court-ordered protection
- People who decline to sign the consent form
- People whose situation makes it impossible to properly explain the study to them or to their nominated trusted person
- People who are pregnant, in labour, or breastfeeding
- People who have a medical reason why they cannot receive a treatment used in this study (confirm with trial site)
- People with a known allergy to contrast dye used in scans, or a severe allergy to iodine
- People with a known active cancer, or who have previously received cancer treatment
- People who have already had a full-body CT scan in the three months before the study
- People with kidney problems where the kidneys are not filtering well enough (a specific kidney function measurement below a set level)
- People with a blood protein condition called monoclonal immunoglobulin
- People with a history of a serious heart or blood vessel event, such as a heart attack, a tear in the main artery (aortic dissection), or loss of blood supply to the bowel or kidneys
- People whose medical situation is an emergency in a way that would prevent the study from being carried out as planned
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesco Macri, MD, Centre Hospitalier Universitaire de Nīmes
Phone: +33.(0)6.19.42.18.52
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Presence/absence of at least one element requiring specific treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.